Ripple’s XRP has printed its first meaningful relief bounce after a prolonged selloff, reclaiming the $2.10–$2.20 zone. Despite the short-term strength, the broader structure remains intact on the downside, and the reaction from the current resistance cluster will determine whether this move is merely a corrective retracement or the beginning of a deeper recovery. XRP […]Ripple’s XRP has printed its first meaningful relief bounce after a prolonged selloff, reclaiming the $2.10–$2.20 zone. Despite the short-term strength, the broader structure remains intact on the downside, and the reaction from the current resistance cluster will determine whether this move is merely a corrective retracement or the beginning of a deeper recovery. XRP […]

Ripple Price Analysis: Has XRP Turned Bullish After Surge to Crucial Zone?

2025/11/25 21:44
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Ripple’s XRP has printed its first meaningful relief bounce after a prolonged selloff, reclaiming the $2.10–$2.20 zone. Despite the short-term strength, the broader structure remains intact on the downside, and the reaction from the current resistance cluster will determine whether this move is merely a corrective retracement or the beginning of a deeper recovery.

XRP Price Analysis

By Shayan

The Daily Chart

The daily timeframe shows XRP rebounding firmly from the $1.90 demand block, a level that has acted as multi-month structural support. The move higher has now carried the price back into the multi-month flag pattern, indicating a bear trap.

This bounce is the first clean retest of the broken lower boundary of the flag. Historically, these retests often serve as decision points before continuation. Unless the asset can reclaim the $2.40–$2.50 region, the broader trend remains bearish, as this zone contains both a major order block and the region where multiple previous daily highs were swept before continuation to the downside.

RSI shows modest bullish momentum, rising from oversold conditions toward mid-range, but has not yet broken its multi-week ceiling. This suggests that while downward exhaustion is present, momentum is not yet strong enough to confirm a macro reversal.

A daily close above the $2.45 pivot would be the first indication of a structural shift. Failure to break through would keep downside targets open toward $1.80 and potentially the deeper demand zone around $1.60 should the broader market weaken again.

The 4-Hour Chart

The 4-hour timeframe highlights a sharp V-shaped rebound, driven initially by short-covering in the $1.95 region. The asset has now reached the confluence of the descending trendline and the red supply block at $2.30–$2.40, where early signs of exhaustion are visible.

RSI is hovering near 70, approaching intraday overbought levels while facing the most significant resistance of the past month. This increases the probability of a short-term pullback into the $2.15–$2.20 area, which has flipped into a temporary support level.

The main factor to watch is whether XRP can break and consolidate above the descending trendline. If this occurs, the next liquidity pockets sit around $2.55 and $2.75. Otherwise, rejection from here would raise the likelihood of another sweep of the $2.00 region before any larger recovery attempt.

Overall, the 4-hour market structure remains bearish until XRP closes decisively above the $2.40–$2.50 region.

The post Ripple Price Analysis: Has XRP Turned Bullish After Surge to Crucial Zone? appeared first on CryptoPotato.

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.3706
$1.3706$1.3706
-1.57%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Share
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Share
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11